Page 5 - Executive Albert Bourla News Today

Pfizer forecast more than $50 billion in 2022 sales for its COVID-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.

Ojais Community Newspaper since 1891, makers of Ojai Valley Guide magazine, local News, Ojai Real Estate Weekly, Events, Arts, Sports, Opinion and more.

Pfizer Inc's experimental antiviral pill to treat Covid-19 was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing

Pfizer Inc's experimental antiviral pill to treat Covid-19 was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing

POLITICO Get the POLITICO Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. 05/12/2021 10:00 AM EDT Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Cares morning newsletter, which is delivered t...

The company is ramping up capacity for the shots, which were developed with German company BioNTech Pfizer sharply increased its projections for 2021 revenues and profits on Tuesday, citing much higher COVID-19 vaccine sales as it targets the inoculations as a "durable" revenue stream. The drugmaker, which has a number of projects to expand vaccinations to additional populations and to provide booster doses, now estimates 2021 revenues of $26 billion from the vaccine, up from $15 billion previo...

Daily Monitor Tuesday May 04 2021 Employees in clean room clothes work on the production of Pfizer/BioNTechs Comirnaty Covid-19 vaccine at the Allergopharma plant in Reinbek near Hamburg, northern Germany, on April 30, 2021, amid the novel coronavirus / COVID-19 pandemic. PHOTO/AFP Summary Pfizer now sees profits of between $3.55 and $3.65 a share for the year, an increase of 45 cents from the previous estimate. Advertisement Pfizer sharply increased its projections for 2021 revenues and profit...

1 hr ago – 5.51AM South America suffers worst death tolls yet The New York Times Bogotá, Colombia | In the capital of Colombia, Bogotá, the mayor warned residents to brace for “the worst two weeks of our lives”. Uruguay, once lauded as a model for keeping the coronavirus under control, now has one of the highest death rates in the world, while the grim daily tallies of the dead have hit records in Argentina, Brazil, Colombia and Peru in recent days. Even Venezuela, where the authoritari...

Pfizer now expects to be able to deliver about 2.5 billion vaccine doses this year and already has signed contracts covering about 1.6 billion of those doses. The company also has begun testing a pill to treat COVID-19.

Pfizer sharply increased its projections for 2021 revenues and profits, citing much higher vaccine sales as it targets the inoculations as a "durable" revenue stream.